First Intragenic Deletion of the PITX2 Gene in Axenfeld-Rieger Syndrome
Author Information
Author(s): de la Houssaye Guillaume, Bieche Ivan, Roche Olivier, Vieira Véronique, Laurendeau Ingrid, Arbogast Laurence, Zeghidi Hatem, Rapp Philippe, Halimi Philippe, Vidaud Michel, Dufier Jean-Louis, Menasche Maurice, Abitbol Marc
Primary Institution: Centre de Recherche Thérapeutique en Ophtalmologie, Université Paris V, Paris, France
Hypothesis
Can an intragenic deletion of the PITX2 gene cause a severe form of Axenfeld-Rieger Syndrome?
Conclusion
The study identifies the first intragenic deletion of the PITX2 gene as a cause of a severe form of Axenfeld-Rieger Syndrome in a family.
Supporting Evidence
- The father and daughter both exhibited severe glaucoma and typical features of Axenfeld-Rieger Syndrome.
- An MRI scan revealed a meningioma in the father, which was not present in the daughter.
- Quantitative genomic PCR analysis identified a 3,059 bp intragenic deletion in the PITX2 gene.
Takeaway
This study found a missing piece in a gene that helps explain why some people have serious eye problems. It shows that sometimes, just looking at the usual parts of a gene isn't enough to find problems.
Methodology
The study used quantitative genomic PCR to identify an intragenic deletion in the PITX2 gene.
Limitations
The study is limited to a single family, and the generalizability of the findings to other cases of Axenfeld-Rieger Syndrome is uncertain.
Participant Demographics
The study involved a father and daughter affected by Axenfeld-Rieger Syndrome.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website